Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 6268

West Hills, CA 91307


Study Summary:

This is a randomized, double-blind, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week main treatment period and an extension assessing the efficacy and safety of ave0010 on top of pioglitazone in patients with type 2 diabetes not adequately controlled with pioglitazone.


Qualified Participants Must:

• Have Type 2 diabetes mellitus, as defined by WHO (1,see Appendix A) diagnosed for at least 1 year at the time of the screening
• Been on a treatment with pioglitazone at a stable dose of at least 30 mg/day for at least 3 months prior to screening visit
• Have HbA1c >=7 % and <=10 % at screening
• In case of treatment with metformin, metformin treatment at a stable dose of at least 1.5 g/day for at least 3 months prior to screening visit


Qualified Participants May Receive:

Office visits, investigational product, and will be compensated at least $50 for travel and time.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.